CTI BioPharma Revenue 2006-2019 | CTIC

CTI BioPharma revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
CTI BioPharma Annual Revenue
(Millions of US $)
2018 $26
2017 $25
2016 $57
2015 $16
2014 $60
2013 $35
2012 $
2011 $
2010 $0
2009 $0
2008 $11
2007 $0
2006 $0
2005 $16
CTI BioPharma Quarterly Revenue
(Millions of US $)
Q2 2019 $0
Q1 2019 $1
Q4 2018 $14
Q3 2018 $1
Q2 2018 $1
Q1 2018 $11
Q4 2017 $0
Q3 2017 $2
Q2 2017 $22
Q1 2017 $1
Q4 2016 $9
Q3 2016 $4
Q2 2016 $7
Q1 2016 $36
Q4 2015 $11
Q3 2015 $1
Q2 2015 $1
Q1 2015 $3
Q4 2014 $18
Q3 2014 $40
Q2 2014 $1
Q1 2014 $1
Q4 2013 $33
Q3 2013 $0
Q2 2013 $0
Q1 2013 $1
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010 $0
Q3 2010
Q2 2010 $0
Q1 2010 $0
Q4 2009 $0
Q3 2009 $0
Q2 2009 $0
Q1 2009 $0
Q4 2008 $3
Q3 2008 $3
Q2 2008 $3
Q1 2008 $3
Q4 2007 $0
Q3 2007 $0
Q2 2007 $0
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $1
Q3 2005 $1
Q2 2005 $7
Q1 2005 $6
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.049B $0.026B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.114B 35.79
Astellas Pharma (ALPMY) Japan $28.076B 13.77
Takeda Pharmaceutical (TAK) Japan $26.841B 8.38
Eisai (ESALY) Japan $14.517B 24.96
UCB SA (UCBJF) Belgium $14.267B 0.00
Grifols, S.A (GRFS) Spain $14.246B 18.17
Merck (MKGAF) Germany $13.409B 18.30
Ionis Pharmaceuticals (IONS) United States $9.397B 20.27
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.620B 0.00
IPSEN SA ADR (IPSEY) France $8.399B 0.00
Sage Therapeutics (SAGE) United States $8.312B 0.00
Catalent (CTLT) United States $7.586B 30.03
Jazz Pharmaceuticals (JAZZ) Ireland $7.443B 9.80
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.793B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.102B 18.34
FibroGen (FGEN) United States $3.698B 92.50
United Therapeutics (UTHR) United States $3.500B 0.00
Nektar Therapeutics (NKTR) United States $3.495B 0.00
Evotec AG (EVTCY) Germany $3.369B 46.12
Taro Pharmaceutical Industries (TARO) Israel $3.077B 11.03
Tilray (TLRY) Canada $2.985B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.858B 65.52
PTC Therapeutics (PTCT) United States $2.543B 0.00
Portola Pharmaceuticals (PTLA) United States $2.081B 0.00
Xencor (XNCR) United States $2.009B 43.80
Zogenix (ZGNX) United States $1.861B 0.00
Heron Therapeutics (HRTX) United States $1.637B 0.00
USANA Health Sciences (USNA) United States $1.602B 16.07
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.551B 56.44
Corcept Therapeutics (CORT) United States $1.520B 20.89
Ironwood Pharmaceuticals (IRWD) United States $1.510B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.366B 22.53
Theravance Biopharma (TBPH) Cayman Islands $1.341B 0.00
Radius Health (RDUS) United States $1.315B 0.00
Aerie Pharmaceuticals (AERI) United States $1.062B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.044B 4.65
Spectrum Pharmaceuticals (SPPI) United States $1.034B 0.00
ArQule (ARQL) United States $0.950B 0.00
Endo (ENDP) Ireland $0.897B 1.58
TherapeuticsMD (TXMD) United States $0.808B 0.00
Concordia (CXRXF) Canada $0.671B 0.00
Karyopharm Therapeutics (KPTI) United States $0.655B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.631B 0.00
Akebia Therapeutics (AKBA) United States $0.625B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.592B 0.00
Organogenesis Holdings (ORGO) United States $0.583B 0.00
Lannett Co Inc (LCI) United States $0.561B 5.91
Flexion Therapeutics (FLXN) United States $0.538B 0.00
Translate Bio (TBIO) United States $0.531B 0.00
Indivior (INVVY) United States $0.510B 1.84
Dermira (DERM) United States $0.480B 0.00
ImmunoGen (IMGN) United States $0.480B 0.00
Aptorum Group (APM) China $0.478B 0.00
Siga Technologies (SIGA) United States $0.459B 1.07
Dova Pharmaceuticals (DOVA) United States $0.458B 0.00
ChemoCentryx (CCXI) United States $0.443B 0.00
Harpoon Therapeutics (HARP) United States $0.429B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.419B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.416B 18.91
Collegium Pharmaceutical (COLL) United States $0.405B 0.00
Ardelyx (ARDX) United States $0.394B 0.00
Innate Pharma SA (IPHYF) France $0.388B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.365B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.348B 0.00
DURECT (DRRX) United States $0.326B 0.00
CV Sciences (CVSI) United States $0.311B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.298B 0.00
Xeris Pharmaceuticals (XERS) United States $0.280B 0.00
OptiNose (OPTN) United States $0.278B 0.00
KalVista Pharmaceuticals (KALV) United States $0.278B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.277B 0.00
Recro Pharma (REPH) United States $0.275B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.265B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
CannTrust Holdings (CTST) Canada $0.228B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
Molecular Templates (MTEM) United States $0.211B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.209B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.194B 0.00
GlycoMimetics (GLYC) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 31.42
Redhill Biopharma (RDHL) Israel $0.168B 0.00
Generex Biotechnology (GNBT) United States $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.159B 0.00
IMV INC (IMV) Canada $0.150B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.146B 0.00
MEI Pharma (MEIP) United States $0.137B 0.00
Cardiome Pharma (CORV) Canada $0.126B 0.00
Jounce Therapeutics (JNCE) United States $0.118B 0.00
Majesco Entertainment (PTE) United States $0.112B 0.00
Mast Therapeutics (SVRA) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ElectroCore (ECOR) United States $0.107B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.093B 0.00
Genocea Biosciences (GNCA) United States $0.090B 0.00
Aquestive Therapeutics (AQST) United States $0.090B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
MediWound (MDWD) Israel $0.087B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.080B 0.00
RENEURON GP (RNUGF) United Kingdom $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 30.24
Natural Alternatives (NAII) United States $0.076B 7.63
Lipocine (LPCN) United States $0.075B 0.00
Novan (NOVN) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.071B 610.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Otonomy (OTIC) United States $0.066B 0.00
China SXT Pharmaceuticals (SXTC) China $0.064B 0.00
Jaguar Animal Health (JAGX) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
Capnia (SLNO) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 1.60
Aclaris Therapeutics (ACRS) United States $0.045B 0.00
Melinta Therapeutics (MLNT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.033B 0.00
Opexa Therapeutics (ACER) United States $0.032B 0.00
Biomerica (BMRA) United States $0.029B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Onconova Therapeutics (ONTX) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Vical (BBI) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00